PMID- 19731625 OWN - NLM STAT- MEDLINE DCOM- 20090928 LR - 20190622 IS - 0065-2598 (Print) IS - 0065-2598 (Linking) VI - 649 DP - 2009 TI - Biomarkers in spondyloarthropathies. PG - 122-32 AB - The study of biomarkers in spondyloarthropathy (SpA) has emerged to be a very important field of research. This is particularly because the two commonly used biomarkers, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), are of very low sensitivity and specificity. The second reason is, with advances in the treatment of SpA by the very expensive tumor necrosis factor-alpha (TNF-alpha) blockers, for cost-effectiveness, clinicians need to be much more accurate in predicting disease progression, evaluating disease activity and monitoring therapeutic efficacy. This review focuses on several biomarkers of promise: matrix metalloproteinases 3 (MMP-3), Type II collagen neoepitope (C2C and C1-2C), C-propeptide of Type II collagen (CPII), aggrecan 846 epitope, macrophage colony stimulating factor (M-CSF), serum amyloid A (SAA) and Interleukin-6 (IL-6). The results summarized in Table 1 call for a co-ordinated effort for systematic studies of existing biomarkers and for search for new candidates. FAU - Chen, Chun-Hsiung AU - Chen CH AD - Institute of Clinical Medicine, National Yang-Ming University, Veterans General Hospital-Taipei, Taipei, Taiwan. FAU - Yu, David Tak Yan AU - Yu DT FAU - Chou, Chung-Tei AU - Chou CT LA - eng PT - Journal Article PT - Review PL - United States TA - Adv Exp Med Biol JT - Advances in experimental medicine and biology JID - 0121103 RN - 0 (Biomarkers) RN - 0 (Interleukin-6) RN - 0 (Serum Amyloid A Protein) RN - 0 (Tissue Inhibitor of Metalloproteinases) RN - 81627-83-0 (Macrophage Colony-Stimulating Factor) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) SB - IM MH - Biomarkers/*metabolism MH - Disease Progression MH - Humans MH - Interleukin-6/metabolism MH - Macrophage Colony-Stimulating Factor/metabolism MH - Matrix Metalloproteinase 3/metabolism MH - Serum Amyloid A Protein/metabolism MH - Severity of Illness Index MH - Spondylarthropathies/*metabolism/physiopathology MH - Tissue Inhibitor of Metalloproteinases/metabolism RF - 62 EDAT- 2009/09/08 06:00 MHDA- 2009/09/29 06:00 CRDT- 2009/09/08 06:00 PHST- 2009/09/08 06:00 [entrez] PHST- 2009/09/08 06:00 [pubmed] PHST- 2009/09/29 06:00 [medline] AID - 10.1007/978-1-4419-0298-6_9 [doi] PST - ppublish SO - Adv Exp Med Biol. 2009;649:122-32. doi: 10.1007/978-1-4419-0298-6_9.